Upcoming Medical Conferences in ZurichSearch Criteria : Switzerland Zurich
Sep 17 - 19, 2020 | Zurich, Zurich
3rd European Burns Association (EBA) Educational Course is organized by Congress Care and will be held from Sep 17 - 19, 2020 at University Hospital of Zurich, Zurich, Switzerland. Additional details will be posted as soon as they are available.
Sep 24 - 25, 2020 | GBP £1570 | Zurich, Zurich
Clinical Trials - Beyond Borders is organized by Mondial Research Group and will be held from Sep 24 - 25, 2020 at Zurich, Switzerland. Who should attend: Senior level directors, managers and scientists in drug discovery, preclinical development, ADME, DMPK, pharmokinetics, drug metabolism, toxicology, computational chemistry, molecular modeling, cheminformatics, drug design, biomolecular screening, physical chemistry, medicinal chemistry, lead optimization. Senior Executives, Heads and VP's of Applied Research, Applied Biology, Bioinformatics, Biology, Chemistry, Medical Affairs, Pre-Clinical Development, R&D, Regulatory Affairs, Scientific Affairs Description: Clinical Trials - Beyond Borders will explore many aspects of clinical trials in Eastern Europe and Asia. There will be in-depth discussions on the benefits and drawbacks of conducting trials in these regions, as well as the ability for rapid patient recruitment and delivery of top quality data in ever shorter periods of time, and at a lower cost. With the compensation of Western European volunteers and medical personnel reaching similar rates to the United States, clinical development that would have otherwise been conducted in Western Europe is now being pushed into Eastern Europe and other ascending markets. Mondial Research Group will bring together some of the industries leading experts to present and discuss recent changes in logistical, clinical and regulatory climate associated within these regions. This event will also cover topics on outsourcing, in-house trials, regulatory affairs, and cultural differences. Our goal is to provide a better understanding of conducting your clinical trials beyond your regular borders. Additional details will be posted as soon as information is available.